Uncategorized
Alimera Sciences reports $6.7 million quarterly net loss
A first-quarter net loss of $6.7 million was reported by Alimera Sciences, compared with an $11.1 million net loss for the first quarter of 2016. Operating expenses went down from $14.2 million in 2016’s first quarter to $11.5 million in 2017’s first quarter, according to a press release. Research, development and medical affairs expenses went down approximately 30% to $2.1 million.